Seroatlas · Human Serome Atlas

TNFRSF8

Tumor necrosis factor receptor superfamily member 8

Also known as: CD30, D1S166E, KI-1, TNR8_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P28908
Gene
TNFRSF8
Ensembl
ENSG00000120949
Chromosome
1
Canonical length
595 aa
Protein class
Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Plasma membrane

OverviewNCBI Gene

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

595 residues, UniProt reviewed canonical sequence.

>P28908|TNFRSF8
     1  MRVLLAALGL LFLGALRAFP QDRPFEDTCH GNPSHYYDKA VRRCCYRCPM GLFPTQQCPQ
    61  RPTDCRKQCE PDYYLDEADR CTACVTCSRD DLVEKTPCAW NSSRVCECRP GMFCSTSAVN
   121  SCARCFFHSV CPAGMIVKFP GTAQKNTVCE PASPGVSPAC ASPENCKEPS SGTIPQAKPT
   181  PVSPATSSAS TMPVRGGTRL AQEAASKLTR APDSPSSVGR PSSDPGLSPT QPCPEGSGDC
   241  RKQCEPDYYL DEAGRCTACV SCSRDDLVEK TPCAWNSSRT CECRPGMICA TSATNSCARC
   301  VPYPICAAET VTKPQDMAEK DTTFEAPPLG TQPDCNPTPE NGEAPASTSP TQSLLVDSQA
   361  SKTLPIPTSA PVALSSTGKP VLDAGPVLFW VILVLVVVVG SSAFLLCHRR ACRKRIRQKL
   421  HLCYPVQTSQ PKLELVDSRP RRSSTQLRSG ASVTEPVAEE RGLMSQPLME TCHSVGAAYL
   481  ESLPLQDASP AGGPSSPRDL PEPRVSTEHT NNKIEKIYIM KADTVIVGTV KAELPEGRGL
   541  AGPAEPELEE ELEADHTPHY PEQETEPPLG SCSDVMLSVE EEGKEDPLPT AASGK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TNFRSF8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.6
Highest tissue expression
5.1 nTPM

Expression across tissuesHPA

Tissue

  • adipose tissue: 5.1 nTPM
  • breast: 3.3 nTPM
  • appendix: 2.9 nTPM
  • stomach: 2.4 nTPM
  • basal ganglia: 2.1 nTPM
  • heart muscle: 1.9 nTPM

Single-cell type

  • epicardial cells: 100 nCPM
  • mesothelial cells: 36 nCPM
  • neutrophils: 20 nCPM
  • monocytes: 17 nCPM
  • mast cells: 14 nCPM
  • late spermatids: 13 nCPM

Immune cell

  • non-classical monocyte: 97 nTPM
  • intermediate monocyte: 59 nTPM
  • neutrophil: 18 nTPM
  • classical monocyte: 18 nTPM
  • myeloid DC: 8.7 nTPM
  • total PBMC: 8.5 nTPM

Brain region

  • basal ganglia: 4.8 nTPM
  • thalamus: 1.5 nTPM
  • cerebral cortex: 0.7 nTPM
  • medulla oblongata: 0.6 nTPM
  • white matter: 0.5 nTPM
  • choroid plexus: 0.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.36
gnomAD pLI
0.86
gnomAD missense Z
0.94
DepMap mean gene effect
-0.22
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TNFRSF8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TNFRSF8 as an antibody target. Whether an autoantibody or antibody against TNFRSF8 could matter depends on whether native TNFRSF8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TNFRSF8 is annotated at the cell surface, where native TNFRSF8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label TNFRSF8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TNFRSF8. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...